FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905830488> ?p ?o ?g. }

• W2905830488 endingPage "140.e2" @default.
• W2905830488 startingPage "134" @default.
• W2905830488 abstract "Objective To evaluate the association between furosemide exposure and risk of bronchopulmonary dysplasia (BPD). Study design This retrospective cohort study included infants (2004-2015) born at 23-29 weeks gestational age and 501-1249 g birth weight. We compared the demographic and clinical characteristics of infants exposed and not exposed to furosemide between postnatal day 7 and 36 weeks postmenstrual age. We examined the association between furosemide exposure and 2 outcomes: BPD and BPD or death. We performed multivariable probit regression models that included demographic and clinical variables in addition to 2 instrumental variables: furosemide exposure by discharge year, and furosemide exposure by site. Results Of 37 693 included infants, 19 235 (51%) were exposed to furosemide; these infants were more premature and had higher respiratory support. Of 33 760 infants who survived to BPD evaluation, 15 954 (47%) had BPD. An increase in the proportion of furosemide exposure days by 10 percentage points was associated with a decrease in both the incidence of BPD (4.6 percentage points; P = .001), and BPD or death (3.7 percentage points; P = .01). Conclusions More days of furosemide exposure between postnatal day 7 and 36 weeks was associated with decreased risk of BPD and a combined outcome of BPD or death. To evaluate the association between furosemide exposure and risk of bronchopulmonary dysplasia (BPD). This retrospective cohort study included infants (2004-2015) born at 23-29 weeks gestational age and 501-1249 g birth weight. We compared the demographic and clinical characteristics of infants exposed and not exposed to furosemide between postnatal day 7 and 36 weeks postmenstrual age. We examined the association between furosemide exposure and 2 outcomes: BPD and BPD or death. We performed multivariable probit regression models that included demographic and clinical variables in addition to 2 instrumental variables: furosemide exposure by discharge year, and furosemide exposure by site. Of 37 693 included infants, 19 235 (51%) were exposed to furosemide; these infants were more premature and had higher respiratory support. Of 33 760 infants who survived to BPD evaluation, 15 954 (47%) had BPD. An increase in the proportion of furosemide exposure days by 10 percentage points was associated with a decrease in both the incidence of BPD (4.6 percentage points; P = .001), and BPD or death (3.7 percentage points; P = .01). More days of furosemide exposure between postnatal day 7 and 36 weeks was associated with decreased risk of BPD and a combined outcome of BPD or death." @default.
• W2905830488 created "2019-01-01" @default.
• W2905830488 creator A5008852386 @default.
• W2905830488 creator A5029078812 @default.
• W2905830488 creator A5032915456 @default.
• W2905830488 creator A5045067535 @default.
• W2905830488 creator A5067695269 @default.
• W2905830488 creator A5074832771 @default.
• W2905830488 creator A5076556014 @default.
• W2905830488 creator A5077917597 @default.
• W2905830488 creator A5081987147 @default.
• W2905830488 creator A5085954268 @default.
• W2905830488 date "2019-05-01" @default.
• W2905830488 modified "2023-10-15" @default.
• W2905830488 title "Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants" @default.
• W2905830488 cites W1847771980 @default.
• W2905830488 cites W1857797615 @default.
• W2905830488 cites W1911366939 @default.
• W2905830488 cites W1937989175 @default.
• W2905830488 cites W1963682825 @default.
• W2905830488 cites W1979748445 @default.
• W2905830488 cites W1994868010 @default.
• W2905830488 cites W2002782289 @default.
• W2905830488 cites W2006357580 @default.
• W2905830488 cites W2006700687 @default.
• W2905830488 cites W2015605719 @default.
• W2905830488 cites W2028157333 @default.
• W2905830488 cites W2034761619 @default.
• W2905830488 cites W2044999319 @default.
• W2905830488 cites W2053975254 @default.
• W2905830488 cites W2065500254 @default.
• W2905830488 cites W2079030680 @default.
• W2905830488 cites W2084150611 @default.
• W2905830488 cites W2089540389 @default.
• W2905830488 cites W2089588240 @default.
• W2905830488 cites W2100330901 @default.
• W2905830488 cites W2119459491 @default.
• W2905830488 cites W2127065386 @default.
• W2905830488 cites W2132635625 @default.
• W2905830488 cites W2141701667 @default.
• W2905830488 cites W2142912667 @default.
• W2905830488 cites W2155957464 @default.
• W2905830488 cites W2156168620 @default.
• W2905830488 cites W2159323838 @default.
• W2905830488 cites W2166410289 @default.
• W2905830488 cites W2193123881 @default.
• W2905830488 cites W2288537789 @default.
• W2905830488 cites W2313121787 @default.
• W2905830488 cites W2408042766 @default.
• W2905830488 cites W2550859085 @default.
• W2905830488 cites W2555367040 @default.
• W2905830488 cites W2790554076 @default.
• W2905830488 cites W2791556871 @default.
• W2905830488 cites W2791798686 @default.
• W2905830488 cites W2889297652 @default.
• W2905830488 cites W2964226498 @default.
• W2905830488 doi "https://doi.org/10.1016/j.jpeds.2018.11.043" @default.
• W2905830488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6486845" @default.
• W2905830488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30579586" @default.
• W2905830488 hasPublicationYear "2019" @default.
• W2905830488 type Work @default.
• W2905830488 sameAs 2905830488 @default.
• W2905830488 citedByCount "41" @default.
• W2905830488 countsByYear W29058304882019 @default.
• W2905830488 countsByYear W29058304882020 @default.
• W2905830488 countsByYear W29058304882021 @default.
• W2905830488 countsByYear W29058304882022 @default.
• W2905830488 countsByYear W29058304882023 @default.
• W2905830488 crossrefType "journal-article" @default.
• W2905830488 hasAuthorship W2905830488A5008852386 @default.
• W2905830488 hasAuthorship W2905830488A5029078812 @default.
• W2905830488 hasAuthorship W2905830488A5032915456 @default.
• W2905830488 hasAuthorship W2905830488A5045067535 @default.
• W2905830488 hasAuthorship W2905830488A5067695269 @default.
• W2905830488 hasAuthorship W2905830488A5074832771 @default.
• W2905830488 hasAuthorship W2905830488A5076556014 @default.
• W2905830488 hasAuthorship W2905830488A5077917597 @default.
• W2905830488 hasAuthorship W2905830488A5081987147 @default.
• W2905830488 hasAuthorship W2905830488A5085954268 @default.
• W2905830488 hasBestOaLocation W29058304882 @default.
• W2905830488 hasConcept C120665830 @default.
• W2905830488 hasConcept C121332964 @default.
• W2905830488 hasConcept C126322002 @default.
• W2905830488 hasConcept C167135981 @default.
• W2905830488 hasConcept C187212893 @default.
• W2905830488 hasConcept C201903717 @default.
• W2905830488 hasConcept C2777955127 @default.
• W2905830488 hasConcept C2778376644 @default.
• W2905830488 hasConcept C2778721537 @default.
• W2905830488 hasConcept C2779234561 @default.
• W2905830488 hasConcept C54355233 @default.
• W2905830488 hasConcept C61511704 @default.
• W2905830488 hasConcept C66322754 @default.
• W2905830488 hasConcept C71924100 @default.
• W2905830488 hasConcept C72563966 @default.
• W2905830488 hasConcept C86803240 @default.
• W2905830488 hasConceptScore W2905830488C120665830 @default.
• W2905830488 hasConceptScore W2905830488C121332964 @default.

• next